BC Week In Review | Aug 17, 2015
Company News

Multiplicom sales and marketing update

Multiplicom launched the CLL MASTR Plus Kit worldwide for research use only to improve diagnosis of patients with chronic lymphocytic leukemia (CLL). The mutation kit identifies mutations tumor protein p53 (TP53) ; baculoviral IAP repeat-containing...
Items per page:
1 - 1 of 1